Technology Transfer: A Contract Manufacturer's Perspective - Meticulous planning and execution are necessary to ensure a seamless transition of processes between partners. - BioPharm International

ADVERTISEMENT

Technology Transfer: A Contract Manufacturer's Perspective
Meticulous planning and execution are necessary to ensure a seamless transition of processes between partners.


BioPharm International


During routine commercial manufacturing, critical parameters are monitored and trended to ensure that the process is still operating in a valid manner. Reprocessing or rework is allowed at this stage if such processes are being validated under protocol or if such processes have already been validated. Reprocessing or rework requires approval of the sponsor.

ConclusionImplementation of this procedure for process development and transfer enables Diosynth and its customers to use a common language to manage expectations for contracted work.

References1 Diosynth Standard Operating Procedure SOP#80GN1327: Evaluation, Development and Execution of Manufacturing Processes at Diosynth RTP


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here